Evidence map›Paper›PMID 39976477›Full record

ArticleMacromolecular rapid communications2025

From Reduction To Remediation: Sustainable Use of Algal Fibrous Mats for Silver Nanoparticle Synthesis and Dye Removal.

Fatma Rabia Karaduman, Betül Öztürk Köksal, Ayşegül Ülkü Metin, Nesrin Horzum

Abstract read
In one paragraph

Article in Macromolecular rapid communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatma Rabia KaradumanDepartment of Chemistry, Kırıkkale University, Kırıkkale, 71450, Türkiye.ORCID https://orcid.org/0000-0001-7317-3445
Betül Öztürk KöksalNanotechnology Graduate Program, İzmir Katip Çelebi University, İzmir, 35620, Türkiye.
Ayşegül Ülkü MetinDepartment of Chemistry, Kırıkkale University, Kırıkkale, 71450, Türkiye.ORCID https://orcid.org/0000-0001-8494-601X
Nesrin HorzumDepartment of Engineering Sciences, İzmir Katip Çelebi University, İzmir, 35620, Türkiye.ORCID https://orcid.org/0000-0002-2782-0581

Funding

Centers of Material Research and Biotechnology and Bioengineering Research and ApplicationCentral Research Laboratory at İzmir Katip Çelebi University
6 · The paper itself

Abstract

Biogenic synthesis of metal nanoparticles offers a sustainable alternative to traditional methods that often rely on toxic reducing agents, offering an environmentally friendly approach to nanoparticle production. The use of nanofibrous substrates, algal nanofibers (Polyacrylonitrile (PAN)/Cystoseira barbata (Cb)), for the reduction process enhances the efficiency of nanoparticle formation, providing a larger surface area for reaction and ensuring uniform distribution of the synthesized nanoparticles. Following the biogenic synthesis of Ag nanoparticles and their stabilization with xanthan gum (XG), the resulting PAN/Cb/Ag@XG nanofibrous catalyst demonstrates excellent reusability, maintaining its activity and structural integrity even after multiple cycles of use. The stabilization with XG also ensures long-term shelf life by preventing nanoparticle aggregation. Additionally, the nanofibrous material exhibits antimicrobial activity against E. coli and S. aureus. Its dual functionality-targeting harmful pathogens while avoiding secondary pollution-positions them as a sustainable and eco-friendly solution for advanced water purification and disinfection systems.

Indexed as

Anti-Bacterial AgentsColoring AgentsMetal NanoparticlesNanofibersSilverAcrylic ResinsCatalysisEscherichia coliMicrobial Sensitivity TestsOxidation-ReductionPolysaccharides, BacterialStaphylococcus aureusAcrylic ResinsAnti-Bacterial AgentsColoring AgentspolyacrylonitrilePolysaccharides, BacterialSilverxanthan gumbiogenic synthesiselectrospinningnanofibersnanoparticlesreusable photocatalyst

Identifiers

PMID39976477
PMCPMC12227230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.